• 

  Eric Topol to receive Gold Foundation medal for humanism in healthcare

  Topol to be honored alongside Drs. Anthony Fauci and Wayne Riley, as well as hundreds of healthcare professionals for their dedication and compassion during the COVID-19 crisis.  

• 

  At least 1 in 3 people infected with COVID-19 never develop symptoms, according to new analysis

  Findings suggest COVID-19 testing should be expanded to those without symptoms who may be unknowingly spreading the virus to others.

• 

  Answering the Big Questions with Science, Simplified

  How a graduate student’s scientific illustrations have gone viral, leading to an award-winning video series.

• 

  Scripps Research, UC San Diego find first evidence of UK coronavirus variant in California

  Since the team's discovery, several additional cases of the B.1.1.7 coronavirus variant have been identified across California.

• 

  How Scripps Research helped map the course for today’s COVID-19 vaccines

  Structural biologists developed the first detailed images of the coronavirus spike protein and then created a way to stabilize the protein for vaccines.  

• 

  Scientists and public health officials use genomics to understand how COVID-19 spreads in San Diego, neighboring regions

  With funding from the Centers for Disease Control and Prevention, scientists at Scripps Research and UC San Diego are sequencing the virus to help guide local outbreak response.

• 

  Early results from DETECT study suggest fitness trackers and smartwatches can predict COVID-19 infection

  Sensor data from wearable devices can complement virus testing and conventional screening to signal new infections.

• 

  Antibodies co-invented by Scripps Research and IAVI to be developed as a potential COVID-19 therapy

  The monoclonal antibody treatment will be tested in clinical trials, with the goal of reaching patients around the world, including in low- and middle-income countries.    

• 

  Breaking COVID-19’s ‘clutch’ to stop its spread

  The virus that causes COVID-19 uses a clutch-like shifter to enable transcription of one RNA string into multiple proteins, and therein lies a vulnerability. A proof-of-concept study from Disney lab shows it’s possible to eliminate that shifter with an RNA-binding medicinal compound linked to a “trash this” signal.

• 

  Nanoparticle vaccine for COVID-19 spurs robust immune response in preclinical tests

  The novel vaccine technology, developed at Scripps Research, uses virus-like particles to elicit high levels of protective antibodies.